The 9 biotechs that stand to win after the FDA took a new approach to approving Biogen’s Alzheimer’s drug

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

• We found the 9 biotechs that stand to benefit after the FDA approved a new Alzheimer's drug;
• A top investor at General Atlantic explained why he's betting on telemedicine;
• Clover Health got the WallStreetBets treatment, closing up more than 80% on Tuesday.

If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…

Here are the 9 biggest biotech winners after the FDA took an entirely new approach to approve Biogen's Alzheimer's drug

• A historic approval of Biogen's Alzheimer's drug will have ramifications across the drug industry.
• Analysts expect Aduhelm's launch to spur more investor interest in Alzheimer's research.

Here are the nine companies that stand to benefit the most>>

Why General Atlantic's top healthcare dealmaker is betting on telemedicine sticking around long after the pandemic subsides

• Tech innovation is driving growth in healthcare, General Atlantic's Robbert Vorhoff told Insider.
• In-person dealmaking is making a comeback, but in a nuanced way, Vorhoff said.
• The first quarter was one of the busiest ever for healthcare dealmaking, according to Refinitiv.

Read more from the interview here>>

Clover Health gained more than 80% as WallStreetBets fueled the meme-stock rally

• Clover Health, backed by billionaire investor Chamath Palihapitiya, surged on Tuesday.
• Clover Health has become the most-talked-about stock on the WallStreetBets subreddit.
• The WallStreetBets forum has been a key driver of big price moves in meme stocks including GameStop and AMC.

Here's what happened>>

More stories we're reading:

• Amazon Pharmacy is offering six-month prescriptions starting at $6 to manage conditions like high blood pressure and high cholesterol (Bloomberg)
• COVID-19 vaccines could be available for kids as young as 6 months old starting this fall (Insider)
• Participants who took part in the clinical trial for the new Alzheimer's drug Aduhelm reflect on its approval (Stat News)
• The US State Department just relaxed COVID-19 travel advisories on Canada and Mexico (Insider)

- Lydia